Long-term efficacy and safety of a repeat treatment course of rituximab in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors

被引：0
|
作者：
Keystone, E.
Pope, J. E.
Fleischmann, R.
Emery, P.
Chubick, A.
Dougados, M.
Baldassare, A. R.
Bathon, J. M.
Hessey, E.
Totoritis, M.
Cooper, S.
机构：
[1] Univ Toronto, Dept Rheumatol, Toronto, ON, Canada
[2] Univ Western Ontario, St Josephs Hlth Ctr, London, ON N6A 4V2, Canada
[3] Univ Texas, SW Med Ctr, Dallas, TX USA
[4] Gen Infirm, Dept Rheumatol, Leeds LS1 3EX, W Yorkshire, England
[5] Baylor Univ, Med Ctr, Ctr Arthritis, Dallas, TX USA
[6] Hop Cochin, Dept Rheumatol, F-75674 Paris, France
[7] St Louis Univ, Dept Internal Med, St Louis, MO 63103 USA
[8] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD USA
[9] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[10] Biogen Idec, San Diego, CA USA
来源：
JOURNAL OF RHEUMATOLOGY | 2007年 / 34卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1617 / 1618
页数：2
相关论文
共 50 条
  • [21] Long-term efficacy and safety of a repeat treatment course of rituximab in RA patients with an inadequate response to disease-modifying anti-rheumatic drugs
    Emery, P.
    Furst, D. E.
    Ferraccioli, G.
    Udell, J.
    Van Vollenhoven, R. F.
    Rowe, K.
    Agarwa, S.
    Shaw, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 58 - 58
  • [22] Multiple Courses of Rituximab (RTX) Produce Sustained Efficacy in Patients (pts) with Rheumatoid Arthritis (RA) with An Inadequate Response (IR) to One or More TNF Inhibitors
    Keystone, Edward
    Fleischmann, R.
    Emery, Paul
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1294 - 1294
  • [23] Long-term Safety of Rituximab in the Treatment of rheumatoid Arthritis
    Hoefler-Speckner, Simone
    JOURNAL FUR MINERALSTOFFWECHSEL, 2011, 18 (02): : 92 - 92
  • [24] Long-term Safety of Rituximab in the Treatment of rheumatoid Arthritis
    不详
    JOURNAL FUR MINERALSTOFFWECHSEL, 2010, 17 (03): : 128 - 129
  • [25] EFFICACY AND SAFETY OF REPEAT TREATMENT COURSES OF RITUXIMAB IN RA PATIENTS (PTS) WITH INADEQUATE RESPONSE (IR) TO TUMOUR NECROSIS FACTOR (TNF) INHIBITORS: LONG-TERM EXPERIENCE FROM THE REFLEX STUDY
    Keystone, Edward C.
    Fleischmann, Roy M.
    Emery, Paul
    Chubick, Andrew
    Dougados, Maxime R.
    Baldassare, Andrew R.
    Bathon, Joan M.
    Hessey, Eva W.
    Hagerty, David
    Safa-Leathers, Simon
    RHEUMATOLOGY, 2009, 48 : I65 - I66
  • [26] Long-term efficacy and safety of abatacept through 5 years of treatment in rheumatoid arthritis patients with an inadequate response to methotrexate
    Emery, P.
    Kremer, J.
    Moreland, L.
    Russell, A.
    Li, T.
    Aranda, R.
    Becker, J. C.
    Tsai, K.
    Dougados, M.
    Westhovens, R.
    RHEUMATOLOGY, 2008, 47 : II48 - II48
  • [27] Long-term efficacy and safety of a repeat treatment course of rituximab in RA patients with an inadequate response to disease-modifying anti-rheumatic drugs.
    Emery, P.
    Furst, D. E.
    Ferraccioli, G.
    Udell, J.
    van Vollenhoven, R. F.
    Rowe, K.
    Agarwal, S.
    Shaw, T.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S228 - S228
  • [28] Inhibition of radiographic progression with rituximab is not dependent on clinical efficacy: Results from a study in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (reflex)
    Keystone, E.
    Emery, P.
    Peterfy, C. G.
    Tak, P. P.
    Cohen, S. B.
    Genoveses, M. C.
    Williams, S.
    Hagerty, D.
    Cravetss, M. W.
    Shaw, Tm.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 431 - 432
  • [29] Inhibition of radiographic progression with rituximab is not dependent on clinical efficacy: Results from a study in rheumatoid arthritis patients with an inadequate response to one or more TNF inhibitors (reflex)
    Emery, Paul
    Keystone, Edward
    Peterfy, Charles G.
    Tak, Paul-Peter
    Cohen, Stanley B.
    Genovese, Mark C.
    Williams, Sarah
    Hagerty, David
    Cravets, Matthew W.
    Shaw, Tim M.
    RHEUMATOLOGY, 2008, 47 : II50 - II50
  • [30] Oral glucocorticoids have no impact on the efficacy or safety profile of rituximab in rheumatoid arthritis patients with inadequate response to TNF inhibitors (REFLEX study)
    Burmester, G. R.
    Ruderman, E. M.
    Durez, P.
    Loveless, J.
    Kvien, T. K.
    Jackson, C.
    Burke, L.
    Cravets, M.
    White, A. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 180 - 180
12345